Patents by Inventor Judith Louise Flanagan

Judith Louise Flanagan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions, Methods and/or Devices for Prevention and/or Treatment of Dry Eye Disorders
    Publication number: 20210205256
    Abstract: The present disclosure relates to compositions, methods and devices for treating, reducing or preventing one or more eye disorders, particularly dry eye disorders, in a subject by administering an amount of one or more fatty acids and/or fatty acid esters therapeutically effective to inhibit lipase activity while permitting bacterial growth or without substantially altering the dynamic microbial community of the eye. Typically, the fatty acids and/or fatty acid esters are C8 to C16 fatty acids and/or fatty acid esters.
    Type: Application
    Filed: August 17, 2020
    Publication date: July 8, 2021
    Inventors: Hua Zhu, Judith Louise Flanagan
  • Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
    Patent number: 10780071
    Abstract: The present disclosure relates to compositions, methods and devices for treating, reducing or preventing one or more eye disorders, particularly dry eye disorders, in a subject by administering an amount of one or more fatty acids and/or fatty acid esters therapeutically effective to inhibit lipase activity while permitting bacterial growth or without substantially altering the dynamic microbial community of the eye. Typically, the fatty acids and/or fatty acid esters are C8 to C16 fatty acids and/or fatty acid esters.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: September 22, 2020
    Assignee: Brien Holden Vision Institute Limited
    Inventors: Hua Zhu, Judith Louise Flanagan
  • Compositions, Methods and/or Devices for Prevention and/or Treatment of Dry Eye Disorders
    Publication number: 20190022046
    Abstract: The present disclosure relates to compositions, methods and devices for treating, reducing or preventing one or more eye disorders, particularly dry eye disorders, in a subject by administering an amount of one or more fatty acids and/or fatty acid esters therapeutically effective to inhibit lipase activity while permitting bacterial growth or without substantially altering the dynamic microbial community of the eye. Typically, the fatty acids and/or fatty acid esters are C8 to C16 fatty acids and/or fatty acid esters.
    Type: Application
    Filed: May 25, 2018
    Publication date: January 24, 2019
    Inventors: Hua Zhu, Judith Louise Flanagan
  • Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
    Patent number: 10004714
    Abstract: The present disclosure relates to compositions, methods and devices for treating, reducing or preventing one or more eye disorders, particularly dry eye disorders, in a subject by administering an amount of one or more fatty acids and/or fatty acid esters therapeutically effective to inhibit lipase activity while permitting bacterial growth or without substantially altering the dynamic microbial community of the eye. Typically, the fatty acids and/or fatty acid esters are C8 to C16 fatty acids and/or fatty acid esters.
    Type: Grant
    Filed: July 9, 2013
    Date of Patent: June 26, 2018
    Assignee: Brien Holden Vision Institute
    Inventors: Hua Zhu, Judith Louise Flanagan
  • Compositions, Methods and/or Devices For Prevention and/or Treatment Of Dry Eye Disorders
    Publication number: 20150157591
    Abstract: The present disclosure relates to compositions, methods and devices for treating, reducing or preventing one or more eye disorders, particularly dry eye disorders, in a subject by administering an amount of one or more fatty acids and/or fatty acid esters therapeutically effective to inhibit lipase activity while permitting bacterial growth or without substantially altering the dynamic microbial community of the eye. Typically, the fatty acids and/or fatty acid esters are C8 to C16 fatty acids and/or fatty acid esters.
    Type: Application
    Filed: July 9, 2013
    Publication date: June 11, 2015
    Applicant: Brien Holden Vision Institute
    Inventors: Hua Zhu, Judith Louise Flanagan